Resting Energy Expenditure Evaluation in Subjects With Crohn's Disease
REECD
The Effects of Disease Activity on Resting Energy Expenditure in Subjects With Crohn's Disease: A Cross-sectional Study
1 other identifier
observational
150
1 country
1
Brief Summary
The aim of this study is to investigate the effect disease activity on resting energy expenditure (REE), body composition, inflammatory markers, food intake and quality of life in subjects affected by Crohn's Disease (CD)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
February 8, 2017
CompletedFirst Posted
Study publicly available on registry
February 16, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2018
CompletedMay 9, 2017
May 1, 2017
1.5 years
February 8, 2017
May 8, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Resting Energy Expenditure (REE) measured by Indirect Calorimetry (IC) in patients with Crohn's Disease
The measurement of REE by IC is a non-invasive method that measures oxygen consumption and carbon dioxide production and it is generally considered the gold standard in clinical practice.
At baseline
Secondary Outcomes (5)
Body composition assessment by bioelectrical impedence analysis (BIA)
At baseline
Assessment of muscle function by hand-grip strength
At baseline
Food intake evaluation
At baseline
Inflammatory biomarkers
At baseline
Quality of Life (QoL)
At baseline
Study Arms (1)
Subject-CD
Subjects with Crohn's Disease in active or quiescent phase, classified according to Crohn's Disease Activity Index (CDAI \>150 active; CDAI \< 150 quiescent)
Interventions
Eligibility Criteria
Patients attending Gastroenterology Unit
You may qualify if:
- Clinical diagnosis of Crohn's Disease
You may not qualify if:
- Comorbidity affecting energy metabolism (diabetes mellitus, thyroid dysfunction, etc.)
- History of acute or chronic liver or kidney disease
- Current parenteral nutrition
- Presence of fistulae, ileostomy or colostomy
- Presence of extensive small bowel resection (residual small bowel \< 2 meters)
- Pregnancy or lactation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fabrizio Pasanisilead
- Fabiana Castiglionecollaborator
Study Sites (1)
Federico II University Hospital
Napoli, 80131, Italy
Related Publications (6)
Al-Jaouni R, Hebuterne X, Pouget I, Rampal P. Energy metabolism and substrate oxidation in patients with Crohn's disease. Nutrition. 2000 Mar;16(3):173-8. doi: 10.1016/s0899-9007(99)00281-6.
PMID: 10705071BACKGROUNDGong J, Zuo L, Guo Z, Zhang L, Li Y, Gu L, Zhao J, Cao L, Zhu W, Li N, Li J. Impact of Disease Activity on Resting Energy Expenditure and Body Composition in Adult Crohn's Disease: A Prospective Longitudinal Assessment. JPEN J Parenter Enteral Nutr. 2015 Aug;39(6):713-8. doi: 10.1177/0148607114528360. Epub 2014 Mar 25.
PMID: 24668997BACKGROUNDKushner RF, Schoeller DA. Resting and total energy expenditure in patients with inflammatory bowel disease. Am J Clin Nutr. 1991 Jan;53(1):161-5. doi: 10.1093/ajcn/53.1.161.
PMID: 1984342BACKGROUNDRigaud D, Cerf M, Angel Alberto L, Sobhani I, Carduner MJ, Mignon M. [Increase of resting energy expenditure during flare-ups in Crohn disease]. Gastroenterol Clin Biol. 1993;17(12):932-7. French.
PMID: 8125226BACKGROUNDSchneeweiss B, Lochs H, Zauner C, Fischer M, Wyatt J, Maier-Dobersberger T, Schneider B. Energy and substrate metabolism in patients with active Crohn's disease. J Nutr. 1999 Apr;129(4):844-8. doi: 10.1093/jn/129.4.844.
PMID: 10203559BACKGROUNDVaisman N, Dotan I, Halack A, Niv E. Malabsorption is a major contributor to underweight in Crohn's disease patients in remission. Nutrition. 2006 Sep;22(9):855-9. doi: 10.1016/j.nut.2006.05.013.
PMID: 16928471BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor of Internal Medicine
Study Record Dates
First Submitted
February 8, 2017
First Posted
February 16, 2017
Study Start
July 1, 2016
Primary Completion
December 31, 2017
Study Completion
June 30, 2018
Last Updated
May 9, 2017
Record last verified: 2017-05